Yale University School of Medicine - Epilepsy — New Haven, Connecticut

Yale University School of Medicine - Epilepsy is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Yale University School of Medicine - Epilepsy has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Interstitial Lung Disease Due to Systemic Disease, Scleroderma.

Sponsors: Scleroderma Research Foundation, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University School of Medicine - Epilepsy?

Yale University School of Medicine - Epilepsy has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University School of Medicine - Epilepsy conducted?

Yale University School of Medicine - Epilepsy has 1 clinical trials on record, with 1 currently active. Their work covers Interstitial Lung Disease Due to Systemic Disease, Scleroderma.

Is Yale University School of Medicine - Epilepsy accredited by Crixeo Health?

Yale University School of Medicine - Epilepsy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale University School of Medicine - Epilepsy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.